Ultragenyx (RARE) Reports Q3 Loss, Tops Revenue Estimates

Ultragenyx (RARE) came out with a quarterly loss of $1.40 per share versus the Zacks Consensus Estimate of a loss of$1.45. This compares to loss of $2.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.45$1.64 per share when it actually produced a loss of $1.52, delivering a surprise of 7.32%.Over the last four quarters, the company has s ...